BIO vs WST

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 21, 2026

BIO

70.1
AI Score
VS
BIO Wins

WST

36.5
AI Score

Investment Advisor Scores

BIO

70score
Recommendation
BUY

WST

37score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric BIO WST Winner
Revenue 1.24B 1.72B WST
Net Income -155.70M 292.80M WST
Gross Margin 52.7% 36.4% BIO
Net Margin -12.5% 17.1% WST
Operating Income 106.70M 356.20M WST
ROE -2.2% 9.8% WST
ROA -1.5% 7.2% WST
Total Assets 10.25B 4.08B BIO
Cash 517.00M 435.80M BIO
Debt/Equity 0.17 0.07 WST
Current Ratio 3.14 2.82 BIO
Free Cash Flow 144.80M 128.00M BIO

Relative Price Performance (Last 90 Days)

BIO 1M: -5.0% · 3M: +13.9% WST 1M: +6.0% · 3M: +10.7%

Current Technical Phase

BIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 45.8 · Price: $360.50

WST

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.9% over 20 days), RSI 71

RSI (14): 71.0 · Price: $393.48

Fundamentals Snapshot

Metric BIO WST
Market Cap — —
Forward P/E 37.0 39.4
Trailing P/E 44.9 49.8
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.5% 0.4%
Operating Margin 0.1% 0.2%
EPS 7.89 7.81
Dividend Yield — 0.00%

Frequently Asked Questions

Based on our detailed analysis, BIO is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.